The Yin and Yang of Cholesteryl Ester Transfer Protein in Cardiovascular Disease

被引:10
作者
Shah, Prediman K. [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA
关键词
Editorials; atherosclerosis; cholesterol ester transfer proteins; cholesterol; high-density lipoprotein; lipoproteins; prevention; CORONARY-HEART-DISEASE; TORCETRAPIB; RISK; GENE; ATHEROSCLEROSIS; MUTATION; PROGRESSION; FAILURE; WOMEN; MEN;
D O I
10.1161/CIRCULATIONAHA.109.910133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2408 / 2410
页数:3
相关论文
共 24 条
  • [1] Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
    Agerholm-Larsen, B
    Nordestgaard, BG
    Steffensen, R
    Jensen, G
    Tybjærg-Hansen, A
    [J]. CIRCULATION, 2000, 101 (16) : 1907 - 1912
  • [2] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [3] Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
    Boekholdt, SM
    Kuivenhoven, JA
    Wareham, NJ
    Peters, RJG
    Jukema, JW
    Luben, R
    Bingham, SA
    Day, NE
    Kastelein, JJP
    Khaw, KT
    [J]. CIRCULATION, 2004, 110 (11) : 1418 - 1423
  • [4] An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study
    Borggreve, Susanna E.
    Hillege, Hans L.
    Wolffenbuttel, Bruce H. R.
    de Jong, Paul E.
    Zuurman, Mike W.
    van der Steege, Gerrit
    van Tol, Arie
    Dullaart, Robin P. F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) : 3382 - 3388
  • [5] Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
    Bots, Michiel L.
    Visseren, Frank L.
    Evans, Gregory W.
    Riley, Ward A.
    Revkin, James H.
    Tegeler, Charles H.
    Shear, Charles L.
    Duggan, William T.
    Vicari, Ralph M.
    Grobbee, Diederick E.
    Kastelein, John J.
    [J]. LANCET, 2007, 370 (9582) : 153 - 160
  • [6] MOLECULAR-BASIS OF LIPID TRANSFER PROTEIN-DEFICIENCY IN A FAMILY WITH INCREASED HIGH-DENSITY LIPOPROTEINS
    BROWN, ML
    INAZU, A
    HESLER, CB
    AGELLON, LB
    MANN, C
    WHITLOCK, ME
    MARCEL, YL
    MILNE, RW
    KOIZUMI, J
    MABUCHI, H
    TAKEDA, R
    TALL, AR
    [J]. NATURE, 1989, 342 (6248) : 448 - 451
  • [7] A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
    Curb, JD
    Abbott, RD
    Rodriguez, BL
    Masaki, K
    Chen, R
    Sharp, DS
    Tall, AR
    [J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (05) : 948 - 953
  • [8] Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin
    de Haan, Willeke
    de Vries-van der Weij, Jitske
    van der Hoorn, Jose W. A.
    Gautier, Thomas
    van der Hoogt, Caroline C.
    Westerterp, Marit
    Romijn, Johannes A.
    Jukema, J. Wouter
    Havekes, Louis M.
    Princen, Hans M. G.
    Rensen, Patrick C. N.
    [J]. CIRCULATION, 2008, 117 (19) : 2515 - 2522
  • [9] Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
    Forrest, M. J.
    Bloomfield, D.
    Briscoe, R. J.
    Brown, P. N.
    Cumiskey, A-M
    Ehrhart, J.
    Hershey, J. C.
    Keller, W. J.
    Ma, X.
    McPherson, H. E.
    Messina, E.
    Peterson, L. B.
    Sharif-Rodriguez, W.
    Siegl, P. K. S.
    Sinclair, P. J.
    Sparrow, C. P.
    Stevenson, A. S.
    Sun, S-Y
    Tsai, C.
    Vargas, H.
    Walker, M., III
    West, S. H.
    White, V.
    Woltmann, R. F.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (07) : 1465 - 1473
  • [10] ATHEROSCLEROTIC DISEASE IN MARKED HYPERALPHALIPOPROTEINEMIA - COMBINED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC TRIGLYCERIDE LIPASE
    HIRANO, K
    YAMASHITA, S
    KUGA, Y
    SAKAI, N
    NOZAKI, S
    KIHARA, S
    ARAI, T
    YANAGI, K
    TAKAMI, S
    MENJU, M
    ISHIGAMI, M
    YOSHIDA, Y
    KAMEDATAKEMURA, K
    HAYASHI, K
    MATSUZAWA, Y
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) : 1849 - 1856